Brief: Compass Pathways Establishes Strategic Collaboration With Healthport
29/04/2025 12:09
April 29 (Reuters) - Compass Pathways PLC CMPS.O: COMPASS PATHWAYS ESTABLISHES STRATEGIC COLLABORATION WITH HEALTHPORT TO INFORM THE POTENTIAL DELIVERY OF COMP360 SYNTHESIZED PSILOCYBIN TREATMENT IN UNDERSERVED COMMUNITIES Source text: ID:nBw6z9YPLa Further company coverage: CMPS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on COMPASS Pathways
See all newsCompass Pathways PLC reports results for the quarter ended September 30 - Earnings Summary
Corrected: Compass Pathways Q3 net loss narrows on lower R&D charges
Corrected: BRIEF-COMPASS Pathways Q3 EPS USD -0.31
Psychedelic drug developers fall after Usona submits depressive drug application
Compass Pathways PLC expected to post a loss of 45 cents a share - Earnings Preview